Welcome to IGP
The department conducts advanced research and education in areas such as clinical immunology, medical genetics and genomics, pathology, oncology, neuro-oncology, vascular biology, molecular tools and medical radiation sciences.
- Our most recent paper on "The human secretome" highlighting which proteins are secreted into blood and which proteins are secreted locally in different organs #secretome #HumanProteinAtlas https://t.co/mBp1nGPBdG
- Uppsala universitet uppmärksammar Elisabetta Dejana och hennes forskning vid IGP. https://t.co/8ZLbyQEP4f pic.twitter.com/ILxbibHsAM
- Miljonanslag för utveckling av nya cancerterapier: Magnus Essand, professor i genterapi, får 13,5 miljoner kronor av Cancerfonden för utveckling av nya immunbehandlingar mot hjärntumörer, leukemi och lymfom. https://t.co/ygioZzFcsE pic.twitter.com/z3oNkf5Jqe
New research findings from IGP
Drug against epilepsy inhibits tumour development in the brain
Medication against a certain type of epilepsy can be a new way to treat malignant brain tumours in infants. A specific mTOR inhibitor can cross the blood-brain barrier and both reach and attack the tumour where it is located. This is shown by IGP researchers, in collaboration with American and British colleagues, and the results are published in the scientific journal Cell Stem Cell.
New combination of drugs effective against aggressive brain tumour
Researchers at IGP have identified a certain group of patients with malignant glioblastoma brain tumours that respond to a therapy targeting the cancer gene MYCN. The research findings are published in the scientific journal Cell Death & Disease.
Correlation found between loss of chromosome Y and genetic instability
In an international collaboration, researchers from IGP have shown that loss of chromosome Y in the blood in men can function as an indicator of genetic instability, which in turn can affect the susceptibility for cancer in other parts of the body. The study has been published in the journal Nature.